Business Description
GRI Bio Inc
NAICS : 541714
SIC : 2834
ISIN : US3622AW1069
Description
GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist, for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 36.23 | |||||
| Equity-to-Asset | 0.67 | |||||
| Debt-to-Equity | 0.04 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Future 3-5Y EPS without NRI Growth Rate Estimate | 86.51 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 40.31 | |||||
| 9-Day RSI | 44.46 | |||||
| 14-Day RSI | 47.34 | |||||
| 6-1 Month Momentum % | -42.77 | |||||
| 12-1 Month Momentum % | -96.87 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.1 | |||||
| Quick Ratio | 3.1 | |||||
| Cash Ratio | 2.77 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -166.61 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -302.42 | |||||
| ROA % | -169.09 | |||||
| ROIC % | -5934.29 | |||||
| ROC (Joel Greenblatt) % | -7860.28 | |||||
| ROCE % | -282.25 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.05 | |||||
| Price-to-Tangible-Book | 1.04 | |||||
| EV-to-EBIT | -0.28 | |||||
| EV-to-Forward-EBIT | -0.19 | |||||
| EV-to-EBITDA | -0.28 | |||||
| EV-to-Forward-EBITDA | -0.19 | |||||
| EV-to-FCF | -0.18 | |||||
| Price-to-Net-Current-Asset-Value | 1.09 | |||||
| Price-to-Net-Cash | 1.29 | |||||
| Earnings Yield (Greenblatt) % | -357.14 | |||||
| FCF Yield % | -178.68 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:GRI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
GRI Bio Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -53.609 | ||
| Beta | 0 | ||
| Volatility % | 190.47 | ||
| 14-Day RSI | 47.34 | ||
| 14-Day ATR ($) | 0.072691 | ||
| 20-Day SMA ($) | 0.78956 | ||
| 12-1 Month Momentum % | -96.87 | ||
| 52-Week Range ($) | 0.3015 - 65 | ||
| Shares Outstanding (Mil) | 8.93 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
GRI Bio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
GRI Bio Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
GRI Bio Inc Frequently Asked Questions
What is GRI Bio Inc(GRI)'s stock price today?
The current price of GRI is $0.76. The 52 week high of GRI is $65.00 and 52 week low is $0.30.
When is next earnings date of GRI Bio Inc(GRI)?
The next earnings date of GRI Bio Inc(GRI) is .
Does GRI Bio Inc(GRI) pay dividends? If so, how much?
GRI Bio Inc(GRI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers